Počet záznamov: 1
skúšanie klinické, fáza III, ako téma
Č. záznamu d017326 Dátum 06.06.2025 Typ M - MESH Tematický termín skúšanie klinické, fáza III, ako téma Iný termín Slovenčina (Pseudonym) pokusy klinické, tretia fáza, ako téma
Slovenčina (Pseudonym) testy klinické, tretia fáza, ako téma
Slovenčina (Pseudonym) štúdie klinické, fáza III, ako téma
Pozri tiež (Novšie záhlavie) štúdie multicentrické ako téma
MDT E05.318.372.250.250.220N05.715.360.330.250.250.220N06.850.520.450.250.250.220 Poznámka Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. 
predmetové heslo
Počet záznamov: 1